Citadel Advisors
ALAB icon

Citadel Advisors’s Astera Labs ALAB Stock Holding History

Citadel Advisors’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$951M Buy
1,968,700
+961,700
+96% +$255M 0.11% 133
2026
Q1 		$110M Sell
1,007,000
-110,700
-10% -$15.8M 0.02% 745
2025
Q4 		$186M Sell
1,117,700
-438,900
-28% -$73.4M 0.03% 517
2025
Q3 		$305M Buy
1,556,600
+1,051,700
+208% +$173M 0.05% 325
2025
Q2 		$45.7M Buy
504,900
+63,300
+14% +$5M 0.01% 1303
2025
Q1 		$26.4M Buy
441,600
+189,600
+75% +$17.5M 0.01% 1722
2024
Q4 		$33.4M Buy
252,000
+101,400
+67% +$9.52M 0.01% 1639
2024
Q3 		$7.89M Sell
150,600
-7,600
-5% -$357K ﹤0.01% 3263
2024
Q2 		$9.57M Buy
158,200
+85,200
+117% +$5.91M ﹤0.01% 2826
2024
Q1 		$5.42M Buy
+73,000
New +$5.41M ﹤0.01% 3825

Other funds holding ALAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citadel Advisors's ALAB Position: Q2 2026 in Review

Citadel Advisors sold out of Astera Labs (ALAB) in Q2 2026, closing a stake of 302,531 shares — an estimated $80.3M sold.

Citadel Advisors first reported a position in ALAB in Q1 2024 and held it in 8 quarters. The position peaked at $63.9M in Q3 2025. 989 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Citadel Advisors reported no remaining Astera Labs position as of Q2 2026 after selling out during the quarter.
  • Citadel Advisors sold 302,531 Astera Labs shares in Q2 2026, an estimated $80.3M.
  • Citadel Advisors first reported a position in Astera Labs in Q1 2024 and held it in 8 quarters.
  • Citadel Advisors's Astera Labs position peaked at $63.9M in Q3 2025.
  • 989 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.